ZimVie Inc. (NASDAQ:ZIMV) Given Average Recommendation of "Hold" by Analysts

Key Points

• ZimVie Inc. has received an average recommendation of "Hold" from four brokerages, with the average one-year price target set at $17.75.
• The company's stock price remained stable at $18.94 after trading 244,118 shares, significantly lower than its average volume of 327,900 shares.
• ZimVie reported $0.26 earnings per share for its last quarter, exceeding the estimated earnings of $0.21, with quarterly revenue reaching $116.66 million.

ZimVie Inc. (NASDAQ:ZIMV - Get Free Report) has earned a consensus rating of "Hold" from the four brokerages that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation. The average 1 year price target among analysts that have issued a report on the stock in the last year is $17.75.

A number of research firms have commented on ZIMV. B. Riley lowered shares of ZimVie from a "buy" rating to a "neutral" rating and set a $19.00 target price for the company. in a report on Thursday, July 31st. Wall Street Zen cut shares of ZimVie from a "strong-buy" rating to a "buy" rating in a research report on Friday, July 18th. Barclays upgraded shares of ZimVie from an "underweight" rating to an "equal weight" rating and upped their price objective for the company from $9.00 to $19.00 in a research report on Tuesday, July 22nd. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of ZimVie in a research note on Saturday, September 27th.

ZimVie Stock Performance

ZimVie stock remained flat at $18.94 during mid-day trading on Friday. 244,118 shares of the company's stock traded hands, compared to its average volume of 327,900. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.60 and a current ratio of 2.37. The firm has a market capitalization of $534.32 million, a PE ratio of -27.06 and a beta of 2.18. ZimVie has a 52-week low of $8.15 and a 52-week high of $19.01. The business has a fifty day moving average price of $18.88 and a 200 day moving average price of $12.94.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.05. ZimVie had a positive return on equity of 6.37% and a negative net margin of 4.39%.The company had revenue of $116.66 million for the quarter, compared to the consensus estimate of $112.60 million. As a group, research analysts predict that ZimVie will post 0.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in ZIMV. Neuberger Berman Group LLC boosted its position in shares of ZimVie by 1.7% during the 1st quarter. Neuberger Berman Group LLC now owns 1,332,890 shares of the company's stock worth $14,435,000 after acquiring an additional 22,075 shares in the last quarter. American Century Companies Inc. lifted its stake in ZimVie by 11.6% in the 2nd quarter. American Century Companies Inc. now owns 770,759 shares of the company's stock valued at $7,207,000 after purchasing an additional 80,084 shares during the last quarter. Gamco Investors INC. ET AL lifted its stake in ZimVie by 20.1% in the 2nd quarter. Gamco Investors INC. ET AL now owns 764,250 shares of the company's stock valued at $7,146,000 after purchasing an additional 127,909 shares during the last quarter. Millennium Management LLC lifted its stake in ZimVie by 7.7% in the 1st quarter. Millennium Management LLC now owns 707,771 shares of the company's stock valued at $7,644,000 after purchasing an additional 50,805 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in ZimVie by 1.5% in the 2nd quarter. Geode Capital Management LLC now owns 666,745 shares of the company's stock valued at $6,235,000 after purchasing an additional 10,073 shares during the last quarter. Institutional investors and hedge funds own 95.63% of the company's stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.